πŸ‡ΊπŸ‡Έ FDA
Patent

US 7550598

Kinase inhibitors

granted A61PA61P1/04A61P17/06

Quick answer

US patent 7550598 (Kinase inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jun 23 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
47
CPC classes
A61P, A61P1/04, A61P17/06, A61P25/00, A61P25/14